Supply chain of innovation and new product development
- Autori: Mazzola E.; Bruccoleri M.; Perrone G.
- Anno di pubblicazione: 2015
- Tipologia: Articolo in rivista (Articolo in rivista)
- Parole Chiave: Biopharmaceutical industry; New product development; R and D purchasing; R and D selling; Social capital;
- OA Link: http://hdl.handle.net/10447/161655
This paper conceptualizes the supply chain of innovation of a company as its supply chain not related to physical goods exchanges but to R&D commodities exchanges. R&D commodities, being the outcomes of research activities, are for example patents, technologies, research services, studies, projects, etc. Specifically, we focus on the relationship between the activities of purchasing/selling R&D commodities and the propensity of thefirm to develop new products; we examine how the position of thefirm within its innovation network moderates this relationship. The empirical setting of the research consists of a crosssectional dataset of 544 biopharmaceutical companies that have signed 1772 R&D agreements in the years 2006-2010. Wefindfirstly, evidence of the supply chain of innovation (as a natural evolution of the well-acknowledged dual-market model of the biopharmaceutical industry). Secondly, wefind that the relational embeddedness, coming from innovation network, influences the effect of purchasing and selling R&D commodities on new product development. Supporting our theoretical predictions, this paper offers contributions to the scientific literature on supply chain relationships in new product development.